Drug Profile
KK 1
Alternative Names: KK1Latest Information Update: 18 May 2016
Price :
$50
*
At a glance
- Originator Nascent Biotech
- Class Antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Colorectal cancer